U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 501

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr11:111171709-111958707
Carney-Stratakis syndrome, Pheochromocytoma, Paragangliomas with sensorineural hearing loss,
Cowden syndrome 3
Pathogenic
(Aug 4, 2021)
criteria provided, single submitter
2.
GRCh37:
Chr11:111957547-111959745
SDHDCarney-Stratakis syndrome, Pheochromocytoma, Paragangliomas with sensorineural hearing loss,
Cowden syndrome 3
Uncertain significance
(Oct 27, 2021)
criteria provided, single submitter
3.
GRCh37:
Chr11:111171709-111959745
Carney-Stratakis syndrome, Pheochromocytoma, Paragangliomas with sensorineural hearing loss,
Cowden syndrome 3
Pathogenic
(Aug 3, 2022)
criteria provided, single submitter
4.
GRCh37:
Chr11:111957665
GRCh38:
Chr11:112086941
LOC126861339, SDHDG12RCarney-Stratakis syndrome, Cowden syndrome 3, Pheochromocytoma,
Paragangliomas with sensorineural hearing loss
Uncertain significance
(Feb 9, 2022)
criteria provided, single submitter
5.
GRCh37:
Chr11:111958713
GRCh38:
Chr11:112087989
SDHDPheochromocytoma, Paragangliomas with sensorineural hearing loss, Carney-Stratakis syndrome,
Cowden syndrome 3
Likely benign
(Jun 12, 2022)
criteria provided, single submitter
6.
GRCh37:
Chr11:111965622
GRCh38:
Chr11:112094898
SDHDF136L, F97LCowden syndrome 3, Carney-Stratakis syndrome, Pheochromocytoma,
Paragangliomas with sensorineural hearing loss
Uncertain significance
(Feb 3, 2022)
criteria provided, single submitter
7.
GRCh37:
Chr11:111959581
GRCh38:
Chr11:112088857
SDHDCowden syndrome 3, Carney-Stratakis syndrome, Pheochromocytoma,
Paragangliomas with sensorineural hearing loss
Likely benign
(Oct 13, 2022)
criteria provided, single submitter
8.
GRCh37:
Chr11:111959752
GRCh38:
Chr11:112089028
SDHDCowden syndrome 3, Carney-Stratakis syndrome, Pheochromocytoma,
Paragangliomas with sensorineural hearing loss
Likely benign
(Aug 19, 2022)
criteria provided, single submitter
9.
GRCh37:
Chr11:111958630
GRCh38:
Chr11:112087906
SDHDF34LParagangliomas with sensorineural hearing loss, Carney-Stratakis syndrome, Cowden syndrome 3,
Pheochromocytoma
Uncertain significance
(Jul 15, 2022)
criteria provided, single submitter
10.
GRCh37:
Chr11:111957652
GRCh38:
Chr11:112086928
LOC126861339, SDHDCarney-Stratakis syndrome, Cowden syndrome 3, Pheochromocytoma,
Paragangliomas with sensorineural hearing loss
Likely benign
(Apr 29, 2022)
criteria provided, single submitter
11.
GRCh37:
Chr11:111959668
GRCh38:
Chr11:112088944
SDHDA44T, A83TParagangliomas with sensorineural hearing loss, Carney-Stratakis syndrome, Cowden syndrome 3,
Pheochromocytoma
Uncertain significance
(Jul 13, 2022)
criteria provided, single submitter
12.
GRCh37:
Chr11:111958578
GRCh38:
Chr11:112087854
SDHDParagangliomas with sensorineural hearing loss, Pheochromocytoma, Cowden syndrome 3,
Carney-Stratakis syndrome
Uncertain significance
(Apr 17, 2022)
criteria provided, single submitter
13.
GRCh37:
Chr11:111957701
GRCh38:
Chr11:112086977
LOC126861339, SDHDParagangliomas with sensorineural hearing loss, Pheochromocytoma, Carney-Stratakis syndrome,
Cowden syndrome 3
Likely benign
(May 27, 2022)
criteria provided, single submitter
14.
GRCh37:
Chr11:111958590
GRCh38:
Chr11:112087866
SDHDL21PPheochromocytoma, Paragangliomas with sensorineural hearing loss, Carney-Stratakis syndrome,
Cowden syndrome 3
Uncertain significance
(Apr 4, 2022)
criteria provided, single submitter
15.
GRCh37:
Chr11:111959672
GRCh38:
Chr11:112088948
SDHDY84S, Y45SParagangliomas with sensorineural hearing loss, Carney-Stratakis syndrome, Cowden syndrome 3,
Pheochromocytoma
Uncertain significance
(Mar 29, 2022)
criteria provided, single submitter
16.
GRCh37:
Chr11:111959728
GRCh38:
Chr11:112089004
SDHDG103R, G64RParagangliomas with sensorineural hearing loss, Carney-Stratakis syndrome, Cowden syndrome 3,
Pheochromocytoma
Uncertain significance
(Sep 1, 2022)
criteria provided, single submitter
17.
GRCh37:
Chr11:111965607
GRCh38:
Chr11:112094883
SDHDF83SCarney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss, Pheochromocytoma,
Cowden syndrome 3
Likely benign
(Feb 21, 2022)
criteria provided, single submitter
18.
GRCh37:
Chr11:111958630
GRCh38:
Chr11:112087906
SDHDF34LCarney-Stratakis syndrome, Cowden syndrome 3, Pheochromocytoma,
Paragangliomas with sensorineural hearing loss
Uncertain significance
(Feb 8, 2022)
criteria provided, single submitter
19.
GRCh37:
Chr11:111959750
GRCh38:
Chr11:112089026
SDHDCarney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss, Pheochromocytoma,
Cowden syndrome 3
Likely benign
(Oct 13, 2022)
criteria provided, single submitter
20.
GRCh37:
Chr11:111958579
GRCh38:
Chr11:112087855
SDHDCarney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss, Cowden syndrome 3,
Pheochromocytoma
Likely pathogenic
(Jul 19, 2022)
criteria provided, single submitter
21.
GRCh37:
Chr11:111965604
GRCh38:
Chr11:112094880
SDHDH82RCarney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss, Cowden syndrome 3,
Pheochromocytoma
Likely benign
(Aug 9, 2022)
criteria provided, single submitter
22.
GRCh37:
Chr11:111959685
GRCh38:
Chr11:112088961
SDHDC88*, C49*Carney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss, Pheochromocytoma,
Cowden syndrome 3
Pathogenic
(Jan 15, 2022)
criteria provided, single submitter
23.
GRCh37:
Chr11:111965595
GRCh38:
Chr11:112094871
SDHDG79VPheochromocytoma, Carney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss,
Cowden syndrome 3, Hereditary cancer-predisposing syndrome
Conflicting interpretations of pathogenicity
(Jan 16, 2023)
criteria provided, conflicting interpretations
24.
GRCh37:
Chr11:111958574
GRCh38:
Chr11:112087850
SDHDCarney-Stratakis syndrome, Cowden syndrome 3, Pheochromocytoma,
Paragangliomas with sensorineural hearing loss
Likely benign
(Oct 12, 2022)
criteria provided, single submitter
25.
GRCh37:
Chr11:111959613
GRCh38:
Chr11:112088889
SDHDCarney-Stratakis syndrome, Pheochromocytoma, Paragangliomas with sensorineural hearing loss,
Cowden syndrome 3
Likely benign
(Jun 27, 2022)
criteria provided, single submitter
26.
GRCh37:
Chr11:111959724
GRCh38:
Chr11:112089000
SDHDPheochromocytoma, Carney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss,
Cowden syndrome 3
Likely benign
(Dec 8, 2021)
criteria provided, single submitter
27.
GRCh37:
Chr11:111965694
GRCh38:
Chr11:112094970
SDHDCarney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss, Pheochromocytoma,
Cowden syndrome 3
Uncertain significance
(Oct 21, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr11:111958663-111958670
GRCh38:
Chr11:112087939-112087946
SDHDV46fsParagangliomas with sensorineural hearing loss, Pheochromocytoma, Cowden syndrome 3,
Carney-Stratakis syndrome
Pathogenic
(Oct 12, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr11:111958563
GRCh38:
Chr11:112087839
SDHDParagangliomas with sensorineural hearing loss, Pheochromocytoma, Cowden syndrome 3,
Carney-Stratakis syndrome
Likely benign
(Oct 8, 2022)
criteria provided, single submitter
30.
GRCh37:
Chr11:111965513
GRCh38:
Chr11:112094789
SDHDCarney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss, Pheochromocytoma,
Cowden syndrome 3
Likely benign
(Sep 29, 2022)
criteria provided, single submitter
31.
GRCh37:
Chr11:111965688-111965689
GRCh38:
Chr11:112094964-112094965
SDHDCarney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss, Pheochromocytoma,
Cowden syndrome 3
Uncertain significance
(Sep 26, 2022)
criteria provided, single submitter
32.
GRCh37:
Chr11:111965517
GRCh38:
Chr11:112094793
SDHDCarney-Stratakis syndrome, Pheochromocytoma, Paragangliomas with sensorineural hearing loss,
Cowden syndrome 3
Likely benign
(Sep 14, 2022)
criteria provided, single submitter
33.
GRCh37:
Chr11:111965527
GRCh38:
Chr11:112094803
SDHDPheochromocytoma, Paragangliomas with sensorineural hearing loss, Carney-Stratakis syndrome,
Cowden syndrome 3
Uncertain significance
(Aug 16, 2022)
criteria provided, single submitter
34.
GRCh37:
Chr11:111959603
GRCh38:
Chr11:112088879
SDHDA61V, A22VCowden syndrome 3, Carney-Stratakis syndrome, Pheochromocytoma,
Paragangliomas with sensorineural hearing loss
Uncertain significance
(Jun 13, 2022)
criteria provided, single submitter
35.
GRCh37:
Chr11:111958626
GRCh38:
Chr11:112087902
SDHDA33ECowden syndrome 3, Pheochromocytoma, Paragangliomas with sensorineural hearing loss,
Carney-Stratakis syndrome
Uncertain significance
(May 19, 2022)
criteria provided, single submitter
36.
GRCh37:
Chr11:111958678
GRCh38:
Chr11:112087954
SDHDH50QCowden syndrome 3, Pheochromocytoma, Paragangliomas with sensorineural hearing loss,
Carney-Stratakis syndrome
Uncertain significance
(May 19, 2022)
criteria provided, single submitter
37.
GRCh37:
Chr11:111958567
GRCh38:
Chr11:112087843
SDHDParagangliomas with sensorineural hearing loss, Cowden syndrome 3, Carney-Stratakis syndrome,
Pheochromocytoma
Likely benign
(Apr 2, 2022)
criteria provided, single submitter
38.
GRCh37:
Chr11:111958683-111958685
GRCh38:
Chr11:112087959-112087961
SDHDP53delParagangliomas with sensorineural hearing loss, Cowden syndrome 3, Pheochromocytoma,
Carney-Stratakis syndrome
Uncertain significance
(Apr 21, 2022)
criteria provided, single submitter
39.
GRCh37:
Chr11:111965591
GRCh38:
Chr11:112094867
SDHDQ78*, A87V, A126VCarney-Stratakis syndrome, Cowden syndrome 3, Pheochromocytoma,
Paragangliomas with sensorineural hearing loss
Uncertain significance
(Aug 3, 2022)
criteria provided, single submitter
40.
GRCh37:
Chr11:111959625
GRCh38:
Chr11:112088901
SDHDS29R, S68RCarney-Stratakis syndrome, Cowden syndrome 3, Pheochromocytoma,
Paragangliomas with sensorineural hearing loss
Uncertain significance
(Oct 7, 2022)
criteria provided, single submitter
41.
GRCh37:
Chr11:111959693
GRCh38:
Chr11:112088969
SDHDM52T, M91TCarney-Stratakis syndrome, Cowden syndrome 3, Pheochromocytoma,
Paragangliomas with sensorineural hearing loss
Uncertain significance
(Apr 22, 2022)
criteria provided, single submitter
42.
GRCh37:
Chr11:111958613
GRCh38:
Chr11:112087889
SDHDA29TParagangliomas with sensorineural hearing loss, Pheochromocytoma, Carney-Stratakis syndrome,
Cowden syndrome 3, Hereditary cancer-predisposing syndrome
Uncertain significance
(Dec 18, 2022)
criteria provided, multiple submitters, no conflicts
43.
GRCh37:
Chr11:111965550
GRCh38:
Chr11:112094826
SDHDL64PCarney-Stratakis syndrome, Cowden syndrome 3, Pheochromocytoma,
Paragangliomas with sensorineural hearing loss
Likely benign
(Apr 13, 2022)
criteria provided, single submitter
44.
GRCh37:
Chr11:111958593
GRCh38:
Chr11:112087869
SDHDR22PPheochromocytoma, Cowden syndrome 3, Carney-Stratakis syndrome,
Paragangliomas with sensorineural hearing loss
Uncertain significance
(Oct 25, 2022)
criteria provided, single submitter
45.
GRCh37:
Chr11:111965663
GRCh38:
Chr11:112094939
SDHDC111S, C150SPheochromocytoma, Cowden syndrome 3, Carney-Stratakis syndrome,
Paragangliomas with sensorineural hearing loss
Uncertain significance
(Jan 4, 2022)
criteria provided, single submitter
46.
GRCh37:
Chr11:111957646
GRCh38:
Chr11:112086922
LOC126861339, SDHDW5*Pheochromocytoma, Cowden syndrome 3, Carney-Stratakis syndrome,
Paragangliomas with sensorineural hearing loss
Pathogenic
(Jan 17, 2022)
criteria provided, single submitter
47.
GRCh37:
Chr11:111965647
GRCh38:
Chr11:112094923
SDHDH145Y, H106YCarney-Stratakis syndrome, Pheochromocytoma, Paragangliomas with sensorineural hearing loss,
Cowden syndrome 3
Uncertain significance
(Mar 8, 2022)
criteria provided, single submitter
48.
GRCh37:
Chr11:111959637
GRCh38:
Chr11:112088913
SDHDHereditary cancer-predisposing syndrome, Pheochromocytoma, Cowden syndrome 3,
Carney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss
Likely benign
(Jul 14, 2022)
criteria provided, multiple submitters, no conflicts
49.
GRCh37:
Chr11:111957648
GRCh38:
Chr11:112086924
LOC126861339, SDHDR6KHereditary cancer-predisposing syndrome, Pheochromocytoma, Carney-Stratakis syndrome,
Cowden syndrome 3, Paragangliomas with sensorineural hearing loss
Uncertain significance
(Jan 19, 2022)
criteria provided, multiple submitters, no conflicts
50.
GRCh37:
Chr11:111958621
GRCh38:
Chr11:112087897
SDHDI31MPheochromocytoma, Paragangliomas with sensorineural hearing loss, Carney-Stratakis syndrome,
Cowden syndrome 3, Hereditary cancer-predisposing syndrome
Uncertain significance
(Oct 18, 2022)
criteria provided, multiple submitters, no conflicts
51.
GRCh37:
Chr11:111957684-111957685
GRCh38:
Chr11:112086960-112086961
LOC126861339, SDHDPheochromocytoma, Carney-Stratakis syndrome, Cowden syndrome 3,
Paragangliomas with sensorineural hearing loss, Hereditary cancer-predisposing syndrome
Pathogenic/Likely pathogenic
(Jun 9, 2022)
criteria provided, multiple submitters, no conflicts
52.
GRCh37:
Chr11:111965675
GRCh38:
Chr11:112094951
SDHDA154V, A115VPheochromocytoma, Carney-Stratakis syndrome, Cowden syndrome 3,
Paragangliomas with sensorineural hearing loss, Hereditary cancer-predisposing syndrome
Uncertain significance
(Sep 15, 2022)
criteria provided, multiple submitters, no conflicts
53.
GRCh37:
Chr11:111965642-111965647
GRCh38:
Chr11:112094918-112094923
SDHDPheochromocytoma, Carney-Stratakis syndrome, Cowden syndrome 3,
Paragangliomas with sensorineural hearing loss, Hereditary cancer-predisposing syndrome
Conflicting interpretations of pathogenicity
(Jul 26, 2022)
criteria provided, conflicting interpretations
54.
GRCh37:
Chr11:111965551
GRCh38:
Chr11:112094827
SDHDD113H, D74HPheochromocytoma, Paragangliomas with sensorineural hearing loss, Cowden syndrome 3,
Carney-Stratakis syndrome
Uncertain significance
(Aug 22, 2022)
criteria provided, single submitter
55.
GRCh37:
Chr11:111959591
GRCh38:
Chr11:112088867
SDHDA18G, S57CPheochromocytoma, Carney-Stratakis syndrome, Cowden syndrome 3,
Paragangliomas with sensorineural hearing loss, Hereditary cancer-predisposing syndrome
Uncertain significance
(Oct 25, 2022)
criteria provided, multiple submitters, no conflicts
56.
GRCh37:
Chr11:111959653
GRCh38:
Chr11:112088929
SDHDG39S, G78SPheochromocytoma, Carney-Stratakis syndrome, Cowden syndrome 3,
Paragangliomas with sensorineural hearing loss
Uncertain significance
(Aug 16, 2022)
criteria provided, single submitter
57.
GRCh37:
Chr11:111958692
GRCh38:
Chr11:112087968
SDHDH55RParagangliomas with sensorineural hearing loss, Cowden syndrome 3, Carney-Stratakis syndrome,
Pheochromocytoma
Uncertain significance
(Jul 29, 2022)
criteria provided, single submitter
58.
GRCh37:
Chr11:111959598
GRCh38:
Chr11:112088874
SDHDCowden syndrome 3, Carney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss,
Pheochromocytoma, Hereditary cancer-predisposing syndrome
Likely benign
(Oct 13, 2021)
criteria provided, multiple submitters, no conflicts
59.
GRCh37:
Chr11:111959667
GRCh38:
Chr11:112088943
SDHDPheochromocytoma, Paragangliomas with sensorineural hearing loss, Cowden syndrome 3,
Carney-Stratakis syndrome
Likely benign
(Dec 19, 2020)
criteria provided, single submitter
60.
GRCh37:
Chr11:111965680
GRCh38:
Chr11:112094956
SDHDPheochromocytoma, Carney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss,
Cowden syndrome 3
Likely benign
(May 18, 2021)
criteria provided, single submitter
61.
GRCh37:
Chr11:111957702
GRCh38:
Chr11:112086978
LOC126861339, SDHDCarney-Stratakis syndrome, Cowden syndrome 3, Pheochromocytoma,
Paragangliomas with sensorineural hearing loss
Likely benign
(Dec 17, 2021)
criteria provided, single submitter
62.
GRCh37:
Chr11:111965515
GRCh38:
Chr11:112094791
SDHDPheochromocytoma, Carney-Stratakis syndrome, Cowden syndrome 3,
Paragangliomas with sensorineural hearing loss
Likely benign
(Oct 20, 2022)
criteria provided, single submitter
63.
GRCh37:
Chr11:111959572
GRCh38:
Chr11:112088848
SDHDPheochromocytoma, Carney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss,
Cowden syndrome 3
Likely benign
(Apr 26, 2022)
criteria provided, single submitter
64.
GRCh37:
Chr11:111965562
GRCh38:
Chr11:112094838
SDHDM68TParagangliomas with sensorineural hearing loss, Carney-Stratakis syndrome, Cowden syndrome 3,
Pheochromocytoma
Likely benign
(Oct 4, 2021)
criteria provided, single submitter
65.
GRCh37:
Chr11:111957688
GRCh38:
Chr11:112086964
LOC126861339, SDHDPheochromocytoma, Cowden syndrome 3, Paragangliomas with sensorineural hearing loss,
Carney-Stratakis syndrome
Benign
(Feb 12, 2021)
criteria provided, single submitter
66.
GRCh37:
Chr11:111965664
GRCh38:
Chr11:112094940
SDHDCarney-Stratakis syndrome, Pheochromocytoma, Cowden syndrome 3,
Paragangliomas with sensorineural hearing loss, Hereditary cancer-predisposing syndrome
Likely benign
(Jul 29, 2022)
criteria provided, multiple submitters, no conflicts
67.
GRCh37:
Chr11:111957693
GRCh38:
Chr11:112086969
LOC126861339, SDHDPheochromocytoma, Cowden syndrome 3, Paragangliomas with sensorineural hearing loss,
Carney-Stratakis syndrome
Likely benign
(Jul 19, 2022)
criteria provided, single submitter
68.
GRCh37:
Chr11:111959572
GRCh38:
Chr11:112088848
SDHDPheochromocytoma, Paragangliomas with sensorineural hearing loss, Cowden syndrome 3,
Carney-Stratakis syndrome
Likely benign
(Oct 14, 2022)
criteria provided, single submitter
69.
GRCh37:
Chr11:111957664
GRCh38:
Chr11:112086940
LOC126861339, SDHDPheochromocytoma, Cowden syndrome 3, Paragangliomas with sensorineural hearing loss,
Carney-Stratakis syndrome
Likely benign
(Sep 30, 2021)
criteria provided, single submitter
70.
GRCh37:
Chr11:111957698
GRCh38:
Chr11:112086974
LOC126861339, SDHDPheochromocytoma, Cowden syndrome 3, Paragangliomas with sensorineural hearing loss,
Carney-Stratakis syndrome
Likely benign
(Aug 8, 2022)
criteria provided, single submitter
71.
GRCh37:
Chr11:111957700
GRCh38:
Chr11:112086976
LOC126861339, SDHDPheochromocytoma, Cowden syndrome 3, Paragangliomas with sensorineural hearing loss,
Carney-Stratakis syndrome
Likely benign
(Oct 15, 2022)
criteria provided, single submitter
72.
GRCh37:
Chr11:111957696
GRCh38:
Chr11:112086972
LOC126861339, SDHDPheochromocytoma, Cowden syndrome 3, Paragangliomas with sensorineural hearing loss,
Carney-Stratakis syndrome
Likely benign
(Nov 1, 2022)
criteria provided, single submitter
73.
GRCh37:
Chr11:111957658
GRCh38:
Chr11:112086934
LOC126861339, SDHDPheochromocytoma, Cowden syndrome 3, Paragangliomas with sensorineural hearing loss,
Carney-Stratakis syndrome, Hereditary cancer-predisposing syndrome
Likely benign
(Oct 12, 2022)
criteria provided, multiple submitters, no conflicts
74.
GRCh37:
Chr11:111958572-111958573
GRCh38:
Chr11:112087848-112087849
SDHDCarney-Stratakis syndrome, Pheochromocytoma, Paragangliomas with sensorineural hearing loss,
Cowden syndrome 3
Likely benign
(Nov 2, 2021)
criteria provided, single submitter
75.
GRCh37:
Chr11:111965511
GRCh38:
Chr11:112094787
SDHDPheochromocytoma, Carney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss,
Cowden syndrome 3
Likely benign
(Nov 23, 2021)
criteria provided, single submitter
76.
GRCh37:
Chr11:111957695
GRCh38:
Chr11:112086971
LOC126861339, SDHDCowden syndrome 3, Carney-Stratakis syndrome, Pheochromocytoma,
Paragangliomas with sensorineural hearing loss
Likely benign
(Sep 1, 2022)
criteria provided, single submitter
77.
GRCh37:
Chr11:111959644
GRCh38:
Chr11:112088920
SDHDCarney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss, Cowden syndrome 3,
Pheochromocytoma
Likely benign
(Jan 23, 2022)
criteria provided, single submitter
78.
GRCh37:
Chr11:111965510-111965511
GRCh38:
Chr11:112094786-112094787
SDHDParagangliomas with sensorineural hearing loss, Carney-Stratakis syndrome, Cowden syndrome 3,
Pheochromocytoma
Benign
(Apr 13, 2022)
criteria provided, single submitter
79.
GRCh37:
Chr11:111959579
GRCh38:
Chr11:112088855
SDHDCarney-Stratakis syndrome, Pheochromocytoma, Paragangliomas with sensorineural hearing loss,
Cowden syndrome 3
Likely benign
(Oct 20, 2022)
criteria provided, single submitter
80.
GRCh37:
Chr11:111965511
GRCh38:
Chr11:112094787
SDHDCarney-Stratakis syndrome, Pheochromocytoma, Paragangliomas with sensorineural hearing loss,
Cowden syndrome 3
Benign
(Jul 23, 2021)
criteria provided, single submitter
81.
GRCh37:
Chr11:111959616
GRCh38:
Chr11:112088892
SDHDPheochromocytoma, Carney-Stratakis syndrome, Cowden syndrome 3,
Paragangliomas with sensorineural hearing loss
Likely benign
(Oct 27, 2021)
criteria provided, single submitter
82.
GRCh37:
Chr11:111958569
GRCh38:
Chr11:112087845
SDHDPheochromocytoma, Paragangliomas with sensorineural hearing loss, Cowden syndrome 3,
Carney-Stratakis syndrome
Likely benign
(May 12, 2021)
criteria provided, single submitter
83.
GRCh37:
Chr11:111965511
GRCh38:
Chr11:112094787
SDHDCarney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss, Cowden syndrome 3,
Pheochromocytoma
Likely benign
(Sep 14, 2022)
criteria provided, single submitter
84.
GRCh37:
Chr11:111957643
GRCh38:
Chr11:112086919
LOC126861339, SDHDCowden syndrome 3, Carney-Stratakis syndrome, Pheochromocytoma,
Paragangliomas with sensorineural hearing loss
Likely benign
(Sep 26, 2022)
criteria provided, single submitter
85.
GRCh37:
Chr11:111959577
GRCh38:
Chr11:112088853
SDHDCowden syndrome 3, Carney-Stratakis syndrome, Pheochromocytoma,
Paragangliomas with sensorineural hearing loss
Likely benign
(Sep 27, 2022)
criteria provided, single submitter
86.
GRCh37:
Chr11:111965525
GRCh38:
Chr11:112094801
SDHDCowden syndrome 3, Carney-Stratakis syndrome, Pheochromocytoma,
Paragangliomas with sensorineural hearing loss
Likely benign
(Jan 26, 2022)
criteria provided, single submitter
87.
GRCh37:
Chr11:111965577
GRCh38:
Chr11:112094853
SDHDR73KCarney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss, Cowden syndrome 3,
Pheochromocytoma
Likely benign
(Jul 26, 2021)
criteria provided, single submitter
88.
GRCh37:
Chr11:111959747
GRCh38:
Chr11:112089023
SDHDCowden syndrome 3, Carney-Stratakis syndrome, Pheochromocytoma,
Paragangliomas with sensorineural hearing loss
Likely benign
(Nov 1, 2022)
criteria provided, single submitter
89.
GRCh37:
Chr11:111958569
GRCh38:
Chr11:112087845
SDHDCowden syndrome 3, Carney-Stratakis syndrome, Pheochromocytoma,
Paragangliomas with sensorineural hearing loss
Likely benign
(Jun 22, 2021)
criteria provided, single submitter
90.
GRCh37:
Chr11:111959580
GRCh38:
Chr11:112088856
SDHDCarney-Stratakis syndrome, Cowden syndrome 3, Pheochromocytoma,
Paragangliomas with sensorineural hearing loss
Likely benign
(Aug 9, 2022)
criteria provided, single submitter
91.
GRCh37:
Chr11:111959573
GRCh38:
Chr11:112088849
SDHDPheochromocytoma, Carney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss,
Cowden syndrome 3
Likely benign
(Mar 1, 2022)
criteria provided, single submitter
92.
GRCh37:
Chr11:111958666
GRCh38:
Chr11:112087942
SDHDHereditary cancer-predisposing syndrome, Cowden syndrome 3, Paragangliomas with sensorineural hearing loss,
Carney-Stratakis syndrome, Pheochromocytoma
Likely benign
(Sep 19, 2022)
criteria provided, multiple submitters, no conflicts
93.
GRCh37:
Chr11:111959571
GRCh38:
Chr11:112088847
SDHDCarney-Stratakis syndrome, Pheochromocytoma, Paragangliomas with sensorineural hearing loss,
Cowden syndrome 3
Likely benign
(Dec 16, 2021)
criteria provided, single submitter
94.
GRCh37:
Chr11:111959578
GRCh38:
Chr11:112088854
SDHDPheochromocytoma, Carney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss,
Cowden syndrome 3
Likely benign
(Mar 17, 2022)
criteria provided, single submitter
95.
GRCh37:
Chr11:111965532
GRCh38:
Chr11:112094808
SDHDA58VParagangliomas with sensorineural hearing loss, Carney-Stratakis syndrome, Pheochromocytoma,
Cowden syndrome 3
Likely benign
(May 13, 2021)
criteria provided, single submitter
96.
GRCh37:
Chr11:111957690
GRCh38:
Chr11:112086966
LOC126861339, SDHDParagangliomas with sensorineural hearing loss, Carney-Stratakis syndrome, Pheochromocytoma,
Cowden syndrome 3
Likely benign
(Mar 15, 2021)
criteria provided, single submitter
97.
GRCh37:
Chr11:111959691
GRCh38:
Chr11:112088967
SDHDCarney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss, Pheochromocytoma,
Cowden syndrome 3
Likely benign
(Feb 17, 2021)
criteria provided, single submitter
98.
GRCh37:
Chr11:111959571
GRCh38:
Chr11:112088847
SDHDCarney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss, Pheochromocytoma,
Cowden syndrome 3
Likely benign
(Jul 26, 2021)
criteria provided, single submitter
99.
GRCh37:
Chr11:111958564
GRCh38:
Chr11:112087840
SDHDCarney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss, Pheochromocytoma,
Cowden syndrome 3
Likely benign
(Jul 1, 2022)
criteria provided, single submitter
100.
GRCh37:
Chr11:111959720
GRCh38:
Chr11:112088996
SDHDT100I, T61ICarney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss, Cowden syndrome 3,
Pheochromocytoma
Uncertain significance
(Sep 27, 2022)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination